Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders

As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes?For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.Photo Credit: Getty ImagesTo PrepareReview the Resources for this module and reflect on the different health needs and body systems presented.Your Instructor will assign you a complex case study to focus on for this Discussion.Consider how you will practice critical decision making for prescribing appropriate drugs and treatment to address the complex patient health needs in the patient case study you selected.BELOW IS THE QUESTION————————Post a brief description of your patient’s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.BELOW IS THE REQUIRED READING—————————–Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.Chapter 46, “Anticoagulant and Antiplatelet Drugs” (pp. 364-371)Chapter 47, “Drugs for Deficiency Anemias” (pp. 389-396)Chapter 50, “Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications” (pp. 425-436)Chapter 51, “Birth Control” (pp. 437-446)Chapter 52, “Androgens” (pp. 447-453)Chapter 53, “Male Sexual Dysfunction and Benign Prostatic Hyperplasia” (pp. 454-466)Chapter 70, “Basic Principles of Antimicrobial Therapy” (pp. 651-661)Chapter 71, “Drugs That Weaken the Bacterial Cell Wall I: Penicillins” (pp. 662-668)Chapter 75, “Sulfonamides Antibiotics and Trimethoprim” (pp. 688-694)Chapter 76, “Drug Therapy of Urinary Tract Infections” (pp. 695-699)Chapter 78, “Miscellaneous Antibacterial Drugs” (pp. 711-714)Chapter 79, “Antifungal Agents” (pp. 715-722)Chapter 80, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 723-743)Chapter 82, “Drug Therapy of Sexually Transmitted Diseases” (pp. 763-770)Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015). Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male, 18(1), 5-15. doi:10.3109/13685538.2015.1004049This article presents recommendations on the diagnosis, treatment, and monitoring of hypogonadism in men. Reflect on the concepts presented and consider how this might impact your role as an advanced practice nurse in treating men’s health disorders.Montaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., … Kendall, P. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV Treatment as Prevention” experience in a Canadian setting. PLoS ONE, 9(2), e87872. Retrieved from https://doi.org/10.1371/journal.pone.0087872This study examines HAART therapy and its sustainability and profound population-level decrease in morbidity, mortality, and HIV transmission.Roberts, H., & Hickey, M. (2016). Managing the menopause: An update. Maturitas, 86(2016), 53-58. .https://doi.org/10.1016/j.maturitas.2016.01.007This article provides an update on treatments on Vasomotor symptoms (VMS), genito-urinary syndrome of menopause (GSM), sleep disturbance, sexual dysfunction, and mood disturbance that are common during the menopause transition.Agency for Healthcare Research and Quality. (2014). Guide to clinical preventive services, 2014: Section 2. Recommendations for adults. Retrieved from http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/guide/section2.htmlThis website lists various preventive services available for men and women and provides information about available screenings, tests, preventive medication, and counseling.BELOW IS THE CASE STUDY———————Case Study 2A 46-year-old, 230lb woman with a family history of breast cancer. She is up to date on yearly mammograms. She has a history of HTN. She complains of hot flushing, night sweats, and genitourinary symptoms. She had felt well until 1 month ago and she presented to her gynecologist for her annual gyn examination and to discuss her symptoms. She has a history of ASCUS about 5 years ago on her pap, other than that, Pap smears have been normal. Home medications are Norvasc 10mg qd and HCTZ 25mg qd. Her BP today is 150/90. She has regular monthly menstrual cycles. Her LMP was 1 month ago.Please make sure to use APA format 7th edition and make sure to add 5 references not more than 5 years old.PLEASE MAKE SURE TO GO THROUGH THE QUESTION AND ANSWER THE WAY IT WAS ASKED AND ALSO MAKE SURE TO GO THROUGH THE RUBIC PROVIDED..please make sure to use INTEXT citation. CORE SKILL: reasoning about COMORBIDITY — how two or more conditions interact so that treating one can worsen another, and how the pathophysiologies compound.
THE ORGANIZING IDEA: comorbid disease is not additive, it is INTERACTIVE. The graded insight is naming a specific interaction and its mechanism.
WORKED EXAMPLE — the pregnant patient with hypertension, diabetes, and recent TB from the prompt: (1) ACE INHIBITORS AND ARBs ARE CONTRAINDICATED IN PREGNANCY (fetal renal injury, oligohydramnios) — so switch to labetalol, nifedipine, or methyldopa. (2) Diabetes in pregnancy requires INSULIN as the standard, and pregnancy itself is an insulin-RESISTANT state (placental hormones — human placental lactogen), so requirements rise through gestation. (3) TB treatment: ISONIAZID causes PERIPHERAL NEUROPATHY through B6 (pyridoxine) depletion — so co-prescribe pyridoxine, and note this compounds with DIABETIC neuropathy, an interaction that is exactly the sort of thing the assignment is fishing for. RIFAMPIN is a potent CYP INDUCER — it lowers levels of many co-administered drugs and renders hormonal contraception unreliable. Both isoniazid and rifampin are hepatotoxic; add pregnancy’s altered hepatic handling and the risk compounds. (4) Preeclampsia risk is elevated in both chronic hypertension and diabetes.
WOMEN’S HEALTH: contraception and its contraindications (combined hormonal contraceptives are contraindicated with migraine WITH AURA due to stroke risk, and in smokers over 35 — a high-yield safety fact); PCOS (insulin resistance, hyperandrogenism, anovulation); endometriosis; menopause and the HRT story (the WHI trial’s initial reporting caused a collapse in HRT use, and subsequent re-analysis by age and time-since-menopause substantially revised the risk picture — a good example of how evidence gets misread and why appraisal skills matter); osteoporosis (bisphosphonates — take upright with water, fasting; watch osteonecrosis of the jaw and atypical femoral fracture); breast and cervical cancer screening.
MEN’S HEALTH: BPH (alpha-1 blockers — tamsulosin, watch orthostasis and intraoperative floppy iris syndrome; 5-alpha-reductase inhibitors — finasteride, which LOWERS PSA by roughly half, so PSA values must be doubled for interpretation, a classic trap); erectile dysfunction (PDE-5 inhibitors — ABSOLUTELY CONTRAINDICATED WITH NITRATES due to catastrophic hypotension); prostate cancer screening controversy; testosterone replacement.
INFECTIOUS DISEASE: antibiotic selection and STEWARDSHIP; the difference between empiric and targeted therapy; culture BEFORE antibiotics; HIV (PrEP, ART, and the U=U evidence — undetectable equals untransmittable); STIs and expedited partner therapy; latent vs. active TB.
HEMATOLOGIC: anemia — classify by MCV. MICROCYTIC (iron deficiency — and in an adult male or postmenopausal woman, iron deficiency anemia is GI MALIGNANCY UNTIL PROVEN OTHERWISE, which is the single most important clinical reflex in this topic; thalassemia; anemia of chronic disease). MACROCYTIC (B12 — which can cause IRREVERSIBLE neurological damage and can present with normal hemoglobin, so do not wait for anemia; folate — and note that giving folate alone in B12 deficiency corrects the anemia while the neurological damage progresses, which is why you must check both). NORMOCYTIC (acute blood loss, hemolysis, CKD/erythropoietin deficiency). Sickle cell disease and hydroxyurea.

Expert Help With This Assignment — On Your Terms